Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Monday, 12 February 2018, 11:05 HKT/SGT
Share:
    

Source: NEC Corporation
NEC Increases Investment in Sub-Saharan Africa-based ICT Solutions Company XON into a Subsidiary

TOKYO, Feb 12, 2018 - (JCN Newswire) - NEC Corporation (TSE: 6701) today announced an increase in investment in XON Holdings Proprietary Limited (XON), an ICT solutions company based in the Republic of South Africa, making it a subsidiary through NEC Europe Ltd.

XON, a Systems Integrator throughout Sub-Saharan Africa established in 1996, designs, builds, operates, and manages information and communication technology (ICT) solutions created specifically for customers.

In a bid to expand its business in Africa, NEC made an investment in 2015 in XON that saw NEC take up a 25% stake in XON to unlock synergies between NEC's African operation and XON. Following the successful synergies and value created through the first transaction, NEC decided to increase its investment in XON in a second transaction that sees NEC increase its stake in the merged XON-NEC Africa business to 59.1%.

NEC expects rapid growth in its Sub-Saharan Africa business, where a huge market exists for its Safer Cities, Energy, Cybersecurity and Telecommunication solutions, amongst others. The combined XON-NEC Africa business provides NEC with the platform to capitalize on these opportunities.

NEC launched its operations in Africa in 1963 and has continued to contribute to the Continent mainly through building telecommunication and broadcasting infrastructure. In 2011, it established NEC Africa (Pty) Ltd. in South Africa, a company focused on growing NEC's business in the Sub-Saharan region.

"This increased investment in XON will see NEC and XON boost their sales within each other's customers and accelerate growth through the provision of NEC's products and technologies fit for the region. While capitalizing on the large number of advanced IT engineers employed by XON, NEC will bolster its capacity to provide integrated solutions covering consulting, systems construction and maintenance. Thereby, NEC will aim to expand its social solution business in the Sub-Saharan region and in the rest of the African region," said Hironobu Kurosaki, President and CEO, NEC Europe.


Contact:
NEC 
Seiichiro Toda         
s-toda@cj.jp.nec.com 
+81-3-3798-6511


Topic: Press release summary
Source: NEC Corporation

Sectors: Cloud & Enterprise
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.


NEC Corporation Links

http://www.nec.com

https://www.facebook.com/nec.global/

https://twitter.com/NEC_corp

https://www.youtube.com/user/NECglobalOfficial

https://www.linkedin.com/company/nec/

NEC Corporation
Apr 22, 2024 14:09 HKT/SGT
NEC Strengthens Commitment to Space Industry with Investment in Seraphim Space Venture Fund II
Apr 11, 2024 14:10 HKT/SGT
DOCOMO, NTT, NEC and Fujitsu Develop Top-level Sub-terahertz 6G Device Capable of Ultra-high-speed 100 Gbps Transmission
Apr 10, 2024 12:36 HKT/SGT
Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024
Apr 8, 2024 12:45 HKT/SGT
NEC white paper proposes comprehensive process workflow for the application of AI-driven personalized cancer vaccines
Mar 25, 2024 09:08 HKT/SGT
NEC develops marketing strategy planning & effectiveness simulation technology using generative AI
Mar 22, 2024 07:38 HKT/SGT
NEC and NTT successfully conduct first-of-its-kind long-distance transmission experiment over 7,000km using 12-core optical fiber
Mar 21, 2024 09:02 HKT/SGT
NEC and Tokyo Medical and Dental University use AI to assist self-care for chronic lower back pain
Mar 20, 2024 14:30 HKT/SGT
NEC and Skyloom to Pioneer 100 Gbps Space Optical Communications, Transforming Global Internet Connectivity
Mar 7, 2024 10:24 HKT/SGT
NEC named to list of Top 100 Global Innovators by Clarivate for 13th consecutive year
Mar 5, 2024 08:05 HKT/SGT
Transgene, NEC, and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050
More news >>
 News Alerts
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: